A

Allmed Solutions Ltd
TASE:ALMD

Watchlist Manager
Allmed Solutions Ltd
TASE:ALMD
Watchlist
Price: 35.9 ILS 6.85% Market Closed
Market Cap: ₪38.9m

Relative Value

The Relative Value of one ALMD stock under the Base Case scenario is 0.8 ILS. Compared to the current market price of 35.9 ILS, Allmed Solutions Ltd is Overvalued by 98%.

Relative Value is the estimated value of a stock based on various valuation multiples like P/E and EV/EBIT ratios. It offers a quick snapshot of a stock's valuation in relation to its peers and historical norms.

ALMD Relative Value
Base Case
0.8 ILS
Overvaluation 98%
Relative Value
Price
A
Worst Case
Base Case
Best Case

Multiples Across Competitors

ALMD Competitors Multiples
Allmed Solutions Ltd Competitors

All Multiples
P/S
P/E
EV/EBITDA
EV/EBIT
All Countries
Close
Market Cap P/S P/E EV/EBITDA EV/EBIT
IL
Allmed Solutions Ltd
TASE:ALMD
38.9m ILS 0 -2.9 -0.3 -0.3
JP
Hoya Corp
TSE:7741
8.5T JPY 9.5 40.4 25 29.9
CH
Alcon AG
SIX:ALC
31B CHF 3.9 38.2 20 38.8
US
Medline Inc
NASDAQ:MDLN
36.2B USD 0 0 0 0
DK
Coloplast A/S
CSE:COLO B
121.3B DKK 4.4 33.4 15.4 18.3
US
Align Technology Inc
NASDAQ:ALGN
12B USD 3 31.9 14.5 18.4
UK
ConvaTec Group PLC
LSE:CTEC
4.8B GBP 2.8 30 18 29.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
43.8B CNY 9.8 27 24.3 24.3
CA
Bausch + Lomb Corp
NYSE:BLCO
6B USD 1.2 -19.6 19.5 92.2
CH
Ypsomed Holding AG
SIX:YPSN
4.5B CHF 5.7 23.1 15 20.3
KR
HLB Inc
KOSDAQ:028300
7.5T KRW 95 -34.9 -87.2 -82.5
P/E Multiple
Earnings Growth PEG
IL
A
Allmed Solutions Ltd
TASE:ALMD
Average P/E: 32
Negative Multiple: -2.9
N/A N/A
JP
Hoya Corp
TSE:7741
40.4
13%
3.1
CH
Alcon AG
SIX:ALC
38.2
25%
1.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
33.4
22%
1.5
US
Align Technology Inc
NASDAQ:ALGN
31.9
27%
1.2
UK
ConvaTec Group PLC
LSE:CTEC
30
33%
0.9
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
27
9%
3
CA
Bausch + Lomb Corp
NYSE:BLCO
Negative Multiple: -19.6 N/A N/A
CH
Ypsomed Holding AG
SIX:YPSN
23.1
32%
0.7
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -34.9 N/A N/A
EV/EBITDA Multiple
EBITDA Growth EV/EBITDA to Growth
IL
A
Allmed Solutions Ltd
TASE:ALMD
Average EV/EBITDA: 19
Negative Multiple: -0.3
N/A N/A
JP
Hoya Corp
TSE:7741
25
11%
2.3
CH
Alcon AG
SIX:ALC
20
8%
2.5
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
15.4
8%
1.9
US
Align Technology Inc
NASDAQ:ALGN
14.5
13%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
18
10%
1.8
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.3
15%
1.6
CA
Bausch + Lomb Corp
NYSE:BLCO
19.5
21%
0.9
CH
Ypsomed Holding AG
SIX:YPSN
15
21%
0.7
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -87.2 N/A N/A
EV/EBIT Multiple
EBIT Growth EV/EBIT to Growth
IL
A
Allmed Solutions Ltd
TASE:ALMD
Average EV/EBIT: 33.9
Negative Multiple: -0.3
N/A N/A
JP
Hoya Corp
TSE:7741
29.9
N/A N/A
CH
Alcon AG
SIX:ALC
38.8
23%
1.7
US
M
Medline Inc
NASDAQ:MDLN
Not Available N/A N/A
DK
Coloplast A/S
CSE:COLO B
18.3
8%
2.3
US
Align Technology Inc
NASDAQ:ALGN
18.4
16%
1.1
UK
ConvaTec Group PLC
LSE:CTEC
29.3
22%
1.3
CN
Shenzhen New Industries Biomedical Engineering Co Ltd
SZSE:300832
24.3
11%
2.2
CA
Bausch + Lomb Corp
NYSE:BLCO
92.2
60%
1.5
CH
Ypsomed Holding AG
SIX:YPSN
20.3
29%
0.7
KR
H
HLB Inc
KOSDAQ:028300
Negative Multiple: -82.5 N/A N/A